Multi-dimensional orchestration of binders for improved CAR-T immunotherapy

Chaoyang Zhu1, Zhiwu Jiang1, Rui Jing1

  • 1Houston Methodist Neal Cancer Center, Weill Cornell Medicine, Houston, TX, 77030, USA.

Cancer Letters
|June 28, 2026
PubMed
Summary

Optimizing chimeric antigen receptor (CAR)-T cell therapy requires a multidimensional binder design strategy, integrating multiple parameters beyond affinity for enhanced efficacy and safety in cancer treatment.

Related Concept Videos